What Fukuda Denshi does

Fukuda Denshi UK Ltd is the UK subsidiary of Japanese medical device OEM Fukuda Denshi Co., Ltd., incorporated in April 2017 to replace a dormant UK branch dating to December 1996. The company designs and supplies medical devices for cardiology, patient monitoring, telemetry, and vascular screening, anchored by the Dynascope 8000 series critical-care monitors and the VaSera VS-2000 arteriosclerosis screening system, which uses Cardio-Ankle Vascular Index (CAVI) technology validated by 200+ published papers across an installed base of 13,000+ systems worldwide. Underlying the hardware is a connectivity software stack—CVW-6000/DynaBase for centralized remote viewing (up to 128 beds, up to 10 years of storage), F-ConneX/OpenConnect for EMR-agnostic multi-device data routing, EFS-1000 for ECG data management, and SecureConnect for HL7-based EPR interfacing with end-to-end encryption via Black Mesa Systems technology.

The company generates revenue through three streams: medical device hardware sales (patient monitors, ECG recorders, vascular screening, telemetry, mounting solutions), recurring enterprise software licensing (DynaBase, F-ConneX, EFS-1000), and professional services including installation, training, and technical support. Go-to-market is direct enterprise field sales via regional subsidiaries such as Fukuda Denshi UK Ltd, supplemented by a parent-level distributor network covering 75 countries. Pricing is not publicly disclosed; sales are handled through contact forms and account managers targeting hospitals and critical care units. AI features are layered onto Holter/ECG platforms and alarm analytics, though no proprietary AI research or model disclosures are evident in the input data.

The entity operates as a private limited company under Fukuda Denshi Co., Ltd., a Japanese corporation with global sales exceeding £950M and no third-party or PE ownership identified. The UK subsidiary itself has 11–50 employees based in Sheffield, and is GDPR-compliant with end-to-end device-to-EPR encryption.

Name

Fukuda Denshi

Legal name

Fukuda Denshi UK Limited

Website

https://fukuda.co.uk

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Fukuda Denshi UK Ltd supplies cardiology instrumentation, patient monitoring, telemetry, and vascular screening medical devices to UK hospitals as a subsidiary of Japanese OEM Fukuda Denshi Co., Ltd., complemented by an enterprise connectivity software stack for EMR/EPR integration.

Ownership category

akta.pro rank

Product category

Medical Devices (Cardiology & Patient Monitoring)

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiology Telemedicine Platforms (HLALAGAB)

Keywords

• Medical device manufacturing
• Patient monitoring systems
• Cardiology instrumentation
• Vascular screening equipment
• ECG data management

Headquarters

HQ city

Sheffield

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device Hardware Sales: Sale of patient monitoring systems, ECG recorders, vascular screening devices, ultrasound technologies, telemetry equipment, and mounting solutions to healthcare facilities.
2. Enterprise Software Solutions: Enterprise software licensing including DynaBase CVW central viewing, F-ConneX connectivity platform, and EFS-1000 ECG data management. Software provides interoperability, alarm analysis, and data analytics capabilities.
3. Professional Services: Customer training services for devices and products, installation, and technical support services.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Fukuda Denshi designs, manufactures, and supplies medical devices and enterprise software solutions for cardiology, patient monitoring, telemetry, vascular screening, and diagnostic ultrasound. Its integrated ecosystem combines hardware products such as Dynascope patient monitors, ECG recorders, central stations, and the VaSera vascular screening system with enterprise software platforms (CVW-6000, F-ConneX, EFS-1000) that connect devices to centralized EMR/EPR systems across the care continuum.

Product overview

Fukuda Denshi is a global market leader in cardiology instrumentation, patient monitoring, and ultrasound technologies offering a comprehensive portfolio of medical equipment solutions with over £950 million in global sales and presence in 75 countries. The company's product portfolio consists of a unified care continuum architecture built around the Dynascope 8000 series patient monitors as the core hardware platform, which seamlessly integrates with the Care Continuum Model software framework. Connectivity is enabled through the CVW-6000 (Central Viewing Window/DynaBase) for centralized remote monitoring, F-ConneX for enterprise multi-device connectivity, and EFS-1000 for ECG data management. The Dynabase Alarm Analysis module provides built-in data analytics for next-generation clinical applications, while SecureConnect handles EPR connectivity via HL7 interfaces with Black Mesa Systems security technology. The VS-2000 Vasera vascular screening system serves as a separate diagnostic product line for arteriosclerosis screening.

Differentiator

Problem solved

Functional benefit

Brands

• VaSera: Vascular screening system for arteriosclerosis screening with CAVI measurement technology. VS-2000 is the specific product model.
• Dynascope
• CVW-6000
• F-ConneX
• EFS-1000
• DynaBase
• SecureConnect
• Dynabase

Products and services

• CVW-6000 (Central Viewing Window / DynaBase) A secure software application for remote centralized patient monitoring that connects to central monitors and up to 128 beds, enabling proactive individual patient monitoring regardless of viewer location. Provides 14-day storage of patient vitals and waveforms (extendable to 10 years), supports up to 256 waveforms, and integrates with SecureConnect for EPR connectivity. Targeted at hospitals and critical care units.
• F-ConneX (OpenConnect Platform) Enterprise multi-device connectivity platform that connects multiple device types and manufacturers, sending data to a central EMR. EMR-agnostic with multimodal clinical data, device mapping, parameter lookup, and clinical AI capabilities. Targeted at hospitals needing interoperability across mixed device fleets.
• EFS-1000 ECG Data Management System Centralizes ECG data from diagnostic equipment and patient monitors, providing easy access and real-time comparison of vital information. Coordinates with EMR systems via PDF or DICOM format and integrates with the CVW-6000. Targeted at cardiology departments and hospitals managing ECG archives.
• VaSera VS-2000 Vascular Screening System Vascular screening device for arteriosclerosis screening that measures arterial stiffness via Cardio Ankle Vascular Index (CAVI), a blood pressure-independent measurement. Also calculates Ankle Brachial Index (ABI) and Toe Brachial Index (TBI) for peripheral artery disease assessment. Targeted at preventive healthcare and screening facilities.
• Mounting Solutions Versatile range of mounting solutions for Fukuda Denshi medical devices in hospitals and clinical environments, including wall mounts, central station mounts, pendant mounts, anaesthetic machine mounts, rolling stands, carts, and bespoke solutions.
• Dynascope 8000 Series Patient Monitors Critical care patient monitors delivering accurate clinical information with intuitive controls and unparalleled displays. Supports up to 256 waveforms, 24-hour full disclosure display, and seamless data transfer across multiple units via the Fukuda Connectivity Engine. Targeted at critical care units and hospitals.
• Telemetry Monitoring Solutions Remote patient monitoring solutions enabling continuous wireless monitoring of patient vital signs outside traditional bedside settings. Targeted at hospitals requiring ambulatory monitoring.
• ECG Recorders Diagnostic electrocardiograph devices for capturing and recording cardiac electrical activity. Targeted at cardiology departments and diagnostic facilities.
• Central Stations Centralized monitoring stations for viewing and managing patient data from multiple monitors across hospital units. Targeted at hospitals with multi-bed monitoring requirements.

Quantifiable outcome

• Connects to up to 128 beds from one CVW system
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature6 records

Partnerships

Four partnerships are on record, tiered core and supporting.

• Senzime ABcoreStrategic or Co-development Partner · 1 May 2023Swedish company Senzime AB expanded its partnership with Japanese firm Fukuda Denshi in May 2023 to produce TetraGraph electromyography monitoring systems. The partnership enables Fukuda Denshi to offer comprehensive neuromonitoring solutions alongside its patient monitoring portfolio.
• Black Mesa SystemscoreTechnology or IntegrationFukuda SecureConnect utilizes Black Mesa Systems priority technology for inherent medical device security and added GDPR standards to create a compliant and secure medical device network. This partnership provides end-to-end encryption from device to EPR.
• Amazon Web Services (AWS)supportingTechnology or IntegrationFukuda Denshi's Lead Enterprise Solutions Architect (Justin Ramsaran) holds AWS CCP certification, indicating technical competency in cloud infrastructure for enterprise software solutions.
• IT Industry Leaders (Various)coreStrategic or Co-development PartnerFukuda has developed comprehensive interconnectivity models working with key industry IT leaders to advance the care continuum. The company emphasizes integration with Hospital Information Systems (HIS), EMR/EHR interfaces, and enterprise-wide information systems.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Schiller AG: Swiss-headquartered specialist in cardiology instrumentation, ECG, defibrillation, and patient monitoring with similar European focus. Schiller is closely comparable to Fukuda on cardiology product portfolio and target customers (hospitals, cardiology clinics).
• Nihon Kohden: Japanese-headquartered medical device company and Fukuda's closest direct competitor, with overlapping product lines in patient monitoring, ECG, neurology, and cardiology instrumentation. Comparable in origin, technology stack, and target customer base (hospitals globally), making it the most analogous peer.
• Drägerwerk: German-headquartered direct competitor specializing in critical care patient monitoring, anesthesia, and neonatal care. Dräger's Infinity patient monitoring platform and UK presence make it a comparable peer in Fukuda's primary market segments.
• Spacelabs Healthcare: US-based patient monitoring and clinical information systems provider, part of OSI Systems. Spacelabs competes with Fukuda in continuous patient monitoring and centralized viewing, serving similar hospital and clinical customers.

Emerging players

• Edan Instruments: Chinese medical device manufacturer with growing presence in patient monitoring, ECG, and ultrasound across European markets. Edan competes with Fukuda primarily on cost-competitive hardware in similar hospital use cases.
• Mindray: Chinese medical device manufacturer rapidly expanding in patient monitoring, ECG, and ultrasound with cost-competitive offerings. Mindray competes with Fukuda on price-performance in the same hospital segments and has been gaining share in European tenders.

Broad incumbents

• GE Healthcare: Dominant incumbent in patient monitoring (CARESCAPE), ECG, and hospital-wide clinical informatics. Fukuda's care continuum model competes directly against GE Healthcare's enterprise monitoring strategy, but GE's broader portfolio (imaging, ultrasound, anesthesia) gives it procurement leverage Fukuda lacks.
• Philips (Philips Healthcare): One of the largest global patient monitoring and clinical informatics vendors, with extensive UK/NHS footprint and bundled enterprise contracts. Fukuda competes against Philips across patient monitoring, ECG, and hospital connectivity, though Philips operates at much broader scale and across more clinical domains.
• Hillrom (Baxter): Now part of Baxter, Hillrom was a major patient monitoring and vital signs company with Welch Allyn and Mortara ECG brands. Comparable in cardiology/patient monitoring space, though Baxter operates across a much broader medtech portfolio.

Regional players

• Masimo: US-headquartered patient monitoring specialist known for pulse oximetry and connectivity (Iris, Patient SafetyNet). Masimo's multi-parameter monitoring and clinical AI overlap with Fukuda's patient monitoring and connectivity offerings, though Masimo is stronger in US markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/fukudadenshi
• Facebookfacebook.com/FukudaDenshi
• LinkedInlinkedin.com/company/fukuda-denshi

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fukuda Denshi